Bioelectronics Corp (BIEL)

[srinsocal]

Those that read the 11/2020 CE Mark PR know that it included OTC Sales for RecoveryRx

Along with all EU members many countries in MENA and ASEAN rely on the CE Mark for their Medical Device Approvals. So, no Doctor's prescription needed for RecoveryRx in dozens of countries.

Opens the Sales Market for 33+ Additional Countries

FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices.

The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain. These wearable devices can now be sold over the counter in 33 European Union (EU) countries, and many other non-EU countries like Australia that recognize the CE mark.